The Department of Pharmacology was established at UBC in 1951. A Therapeutics division was subsequently added to add focus to evidence based drug therapy. Recently, the department merged with Anesthesiology to foster interactions between basic and clinical scientists. Faculty members in the department of Anesthesiology, Pharmacology & Therapeutics are engaged in research in areas of neural, cardiovascular, respiratory and clinical pharmacology as well as drug development. Exceptional students with an undergraduate degree may be admitted directly into the Ph.D. program. Some students do a combined M.D./Ph.D. program for which a separate admission into the M.D. program, by the Faculty of Medicine, is required. Students pursuing a Ph.D. will have the opportunity to interact with basic as well as clinical scientists.
The shared research interests in anesthesiology, pharmacology, drug development and therapeutics allow students to gain broad-based exposure to fundamental as well as medically-related aspects of drug research. Research projects in the department are funded by operating grants from CIHR, NSERC, The Heart Foundation, etc. In addition, many of our students receive the highly competitive CIHR and NSRC studentship awards.
Program contact details
- Wynne Leung, firstname.lastname@example.org
Tuition / Program costs
|Fees||Canadian Citizen / Permanent Resident / Refugee / Diplomat||International|
|Installments per year||3||3|
|Tuition per installment||$1,538.45||$2,702.80|
|Tuition per year||$4,615.35||$8,108.40|
|Int. Tuition Award (ITA) per year (if eligible)||$3,200.00 (-)|
|Other Fees and Costs|
|Student Fees (yearly)||$857.00 (approx.)|
|Costs of living (yearly)||starting at $13,561.00 (check cost calculator)|
All fees for the year are subject to adjustment and UBC reserves the right to change any fees without notice at any time, including tuition and student fees. In case of a discrepancy between this webpage and the UBC Calendar, the UBC Calendar entry will be held to be correct.
Recent Doctoral Citations
- Dr. Joanne Yuen Ting Leung: "Dr. Leung's research focused on cardiovascular complications of diabetes. She investigated potential factors that influence contractile functions of the heart and blood vessels in both type 1 and type 2 diabetes. Her results provide important insights on how specific drugs can improve cardiovascular performance in the diabetic population." (May 2015)
- Dr. Suk Kei Cleo Leung: "Dr. Leung showed the new functional roles of two proteins, myoferlin and dysferlin, in normal lungs and in lung cancer. She found that myoferlin plays an important role in the growth and metastasis of lung cancer. Her work identifies the necessity of targeting myoferlin, to prevent the development of lung cancer and prolong the lifespan of patients." (May 2015)
- Dr. Arpeeta Sharma: "Dr. Sharma conducted research into blood vessels in UBC's Department of Pharmacology. She investigated the protective effects of a novel protein that improves blood vessel function and reduces atherosclerosis, a disease in which plaque builds up in the blood vessels. Her findings suggest an alternate treatment strategy for cardiovascular disease." (May 2015)
- Dr. Wan ki Wong: "Dr. Wong studied the blood pressure lowering effects of beta blockers, which are used to treat chest pain. He showed that different sub-types of beta blockers lower blood pressure by different amounts and generally have no effect on pulse pressure. His research provides new information to assist physicians and patients in clinical decision-making." (May 2014)
- Dr. Heidi Noel Boyda: "Dr. Boyda investigated the side-effects of anti-psychotic medication and determined an underlying rationale for how these diabetic-like side-effects occur. Her research may aid psychiatrists to make more informed decisions regarding treatment and monitoring strategies, and offer patients better understanding of the medications they are taking." (November 2013)